Cleared Traditional

K874606 - CATHRA GRAM POSITIVE SCREEN

K874606 is an FDA 510(k) clearance for CATHRA GRAM POSITIVE SCREEN, manufactured by Mct Medical, Inc.. The device is a Class 1 Microbiology device with product code LQL cleared through the Traditional 510(k) pathway after a 179-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1988
Decision
179d
Days
Class 1
Risk

K874606 is an FDA 510(k) clearance for the CATHRA GRAM POSITIVE SCREEN. Classified as Gram Positive Identification Panel (product code LQL), Class I - General Controls.

Submitted by Mct Medical, Inc. (Shoreview, US). The FDA issued a Cleared decision on May 6, 1988 after a review of 179 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K874606

510(k) Number K874606 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 09, 1987
Decision Date May 06, 1988
Days to Decision 179 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
77d slower than avg
Panel avg: 102d · This submission: 179d
Pathway characteristics
Predicate-based equivalence.

LQL Device Classification - Class 1, General Controls

Product Code LQL Gram Positive Identification Panel
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.